Amy E. Geddis

2.1k total citations
42 papers, 1.1k citations indexed

About

Amy E. Geddis is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, Amy E. Geddis has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 12 papers in Genetics and 9 papers in Genetics. Recurrent topics in Amy E. Geddis's work include Platelet Disorders and Treatments (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Blood groups and transfusion (7 papers). Amy E. Geddis is often cited by papers focused on Platelet Disorders and Treatments (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Blood groups and transfusion (7 papers). Amy E. Geddis collaborates with scholars based in United States, India and Canada. Amy E. Geddis's co-authors include Kenneth Kaushansky, Norma E. Fox, Darwin J. Prockop, Hannah M. Linden, Takafumi Nakao, Ian S. Hitchcock, Anne S. Olsen, Veena Sangkhae, Eugene Tkachenko and Sebastian Saur and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cytokine & Growth Factor Reviews.

In The Last Decade

Amy E. Geddis

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. Geddis United States 21 649 354 277 167 160 42 1.1k
Dominique Bluteau France 19 714 1.1× 487 1.4× 319 1.2× 191 1.1× 168 1.1× 22 1.3k
Hideya Ohashi Japan 20 833 1.3× 465 1.3× 269 1.0× 235 1.4× 125 0.8× 44 1.4k
R Schirò Italy 20 558 0.9× 351 1.0× 318 1.1× 255 1.5× 129 0.8× 35 1.2k
Larissa Lordier France 14 428 0.7× 303 0.9× 141 0.5× 74 0.4× 57 0.4× 21 788
Hidekazu Nishikii Japan 18 513 0.8× 360 1.0× 170 0.6× 372 2.2× 63 0.4× 67 1.1k
Caterina Casari France 20 950 1.5× 189 0.5× 164 0.6× 252 1.5× 113 0.7× 58 1.3k
Anne‐Sophie Ribba France 20 867 1.3× 138 0.4× 148 0.5× 385 2.3× 207 1.3× 52 1.2k
Rosa Alba Rana Italy 17 487 0.8× 479 1.4× 484 1.7× 214 1.3× 54 0.3× 37 1.1k
EA Jaffe United States 9 372 0.6× 291 0.8× 121 0.4× 151 0.9× 70 0.4× 9 971

Countries citing papers authored by Amy E. Geddis

Since Specialization
Citations

This map shows the geographic impact of Amy E. Geddis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Geddis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Geddis more than expected).

Fields of papers citing papers by Amy E. Geddis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Geddis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Geddis. The network helps show where Amy E. Geddis may publish in the future.

Co-authorship network of co-authors of Amy E. Geddis

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Geddis. A scholar is included among the top collaborators of Amy E. Geddis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Geddis. Amy E. Geddis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimano, Kristin A., Ghadir Sasa, Larisa Broglie, et al.. (2024). Treatment of relapsed/refractory severe aplastic anemia in children: Evidence‐based recommendations. Pediatric Blood & Cancer. 71(8). e31075–e31075. 1 indexed citations
2.
Shimano, Kristin A., Jennifer Rothman, S. W. Allen, et al.. (2024). Treatment of newly diagnosed severe aplastic anemia in children: Evidence‐based recommendations. Pediatric Blood & Cancer. 71(8). e31070–e31070. 3 indexed citations
3.
Hammill, Adrienne M., Denise M. Adams, Roderic J. Phillips, et al.. (2023). Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response. Pediatric Blood & Cancer. 70(4). e30215–e30215. 12 indexed citations
4.
Duong, Jennifer, et al.. (2022). Sirolimus for management of GI bleeding in blue rubber bleb nevus syndrome: A case series. Pediatric Blood & Cancer. 69(11). e29970–e29970. 2 indexed citations
5.
Richardson, Clare, Jonathan N. Perkins, Dana M. Jensen, et al.. (2022). Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infants. International Journal of Pediatric Otorhinolaryngology. 164. 111371–111371. 3 indexed citations
6.
Mallhi, Kanwaldeep, Kelsey K. Baker, Haydar Frangoul, et al.. (2020). HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide. Biology of Blood and Marrow Transplantation. 26(7). 1332–1341. 20 indexed citations
7.
Burroughs, Lauri M., Akiko Shimamura, Julie‐An Talano, et al.. (2017). Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders. Biology of Blood and Marrow Transplantation. 23(10). 1669–1677. 37 indexed citations
8.
Geddis, Amy E.. (2010). Megakaryopoiesis. Seminars in Hematology. 47(3). 212–219. 66 indexed citations
10.
Geddis, Amy E.. (2009). Congenital Amegakaryocytic Thrombocytopenia and Thrombocytopenia with Absent Radii. Hematology/Oncology Clinics of North America. 23(2). 321–331. 44 indexed citations
11.
Willert, Karl, et al.. (2008). Inhibition of GSK-3β promotes survival and proliferation of megakaryocytic cells through a β-catenin-independent pathway. Cellular Signalling. 20(12). 2317–2323. 19 indexed citations
12.
Geddis, Amy E., Norma E. Fox, Eugene Tkachenko, & Kenneth Kaushansky. (2007). Endomitotic Megakaryocytes that Form a Bipolar Spindle Exhibit Cleavage Furrow Ingression Followed by Furrow Regression. Cell Cycle. 6(4). 455–460. 58 indexed citations
13.
Geddis, Amy E. & Carlo L. Balduini. (2007). Diagnosis of immune thrombocytopenic purpura in children. Current Opinion in Hematology. 14(5). 520–525. 26 indexed citations
14.
Geddis, Amy E. & Kenneth Kaushansky. (2006). Endomitotic Megakaryocytes form a Midzone in Anaphase but Have a Deficiency in Cleavage Furrow Formation. Cell Cycle. 5(5). 538–545. 36 indexed citations
15.
Geddis, Amy E., Norma E. Fox, & Kenneth Kaushansky. (2006). The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels. Experimental Hematology. 34(1). 82–86. 19 indexed citations
17.
Geddis, Amy E., Hannah M. Linden, & Kenneth Kaushansky. (2002). Thrombopoietin: a pan-hematopoietic cytokine. Cytokine & Growth Factor Reviews. 13(1). 61–73. 68 indexed citations
18.
Drachman, Jonathan G., et al.. (2002). Studies with Chimeric Mpl/JAK2 Receptors Indicate That Both JAK2 and the Membrane-proximal Domain of Mpl Are Required for Cellular Proliferation. Journal of Biological Chemistry. 277(26). 23544–23553. 15 indexed citations
19.
Geddis, Amy E., Norma E. Fox, & Kenneth Kaushansky. (2001). Phosphatidylinositol 3-Kinase Is Necessary but Not Sufficient for Thrombopoietin-induced Proliferation in Engineered Mpl-bearing Cell Lines as Well as in Primary Megakaryocytic Progenitors. Journal of Biological Chemistry. 276(37). 34473–34479. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026